PKG Health

PKG Health is a global leader in precision medicine and digital therapeutics, focusing on neurological movement disorders, particularly Parkinson’s disease. Headquartered in Melbourne, Australia, the company operates in over 20 countries, including the US and Europe, and is supported by international investors. The core offering of PKG Health is the PKG® system, an FDA-cleared Class II medical device platform. This system provides continuous, objective assessment of movement disorder symptoms through a wearable device that monitors patient data during daily activities and sleep. It enables clinicians to track disease progression and treatment responsiveness, while also reminding patients to take their medications. The technology benefits patients, caregivers, clinicians, and life science partners by facilitating personalized treatment adjustments and optimizing therapy with advanced analytics. PKG Health aims to improve the quality of life for individuals with neurological conditions by leveraging extensive clinical evidence in neurology. Their innovative approach enhances clinical care, research, and patient outcomes on a global scale.

• Employees 30
• Founded 2007
• Total Funding $20818683